Professor Yunfeng Lin, Chief Scientist of Yunhai Biotech, was awarded the Advanced Materials Laureate (International Advanced Materials Lifetime Achievement Award).

Recently, the International Association of Advanced Material...

Learn More

Professor DeLun Luo, President of Yunhai Bio, Invited to Attend the 2025 “Gusu Dialogue”

To promote the green transformation of the pharmaceutical in...

Learn More

The Recommended National Standard Led by Yunhai Bio Approved for Project Initiation —— Strengthening the Foundation of Biochemical Testing Standards and Promoting the Standardization and Industrialization of Cutting-edge Technologies

On August 15, the 11th meeting of the 3rd National Technical...

Learn More

​2025 Tetrahedral Framework Nucleic Acid Industry Development Forum – Media Report

The 2nd Tetrahedral Framework Nucleic Acid Industry Developm...

Learn More

The 2nd Tetrahedral Framework Nucleic Acid Industry Development Forum Held in Chengdu

On June 29, the 12th DNA Nanotechnology Symposium of the Chi...

Learn More

The Second Academic Committee Meeting of the Joint Engineering Center for Tetrahedral Framework Nucleic Acids Successfully Held

On the afternoon of June 28, the Second Academic Committee M...

Learn More

THE 2ND TETRAHEDRAL FRAMEWORK NUCLEIC ACID INDUSTRY DEVELOPMENT FORUM 2025

The 2nd Tetrahedral Framework Nucleic Acid Industry Develop...

Learn More

Tetrahedral Framework Nucleic Acid: Powering the Hair Follicle Defense Battle! — A Hundred-Billion Blue Ocean • Nanotechnology • Precision Targeting

As life pressures and irregular routines become the norm for...

Learn More

Professor Yunfeng Lin, Chief Scientist of Yunhai Biotech, Invited to Attend the 2025 Belt and Road International Forum on Greater Health

In response to national initiatives and to align with China’...

Learn More

​​Invitation Letter | The 2nd Nucleic Acid Tetrahedron Industry Development Forum 2025​

Learn More

​​AI Empowers the Development of Innovative Nucleic Acid Drugs (Part 2)​

With the rapid rise of artificial intelligence (AI) in the p...

Learn More

Nucleic Acid Tetrahedron Delivery of saRNA: Bringing New Hope for the Treatment of Retinal Diseases

Retinal ischemia - reperfusion injury (such as glaucoma and ...

Learn More

2024 Research Achievements Summary of Professor Yunfeng Lin’s Team at Yunhai Bio

As we look back on 2024, it has been another remarkable year...

Learn More

Yunhai Bio: Empowering Traditional Chinese Medicine with Tetrahedral Framework Nucleic Acids, Pioneering the Modernization of TCM through Nanotechnology

Recently, Yunhai Bio has launched the groundbreaking "Qinghe...

Learn More

Yunhai Bio Launches First Consumer-Grade Product Based on Tetrahedral Framework Nucleic Acids A New Era of Hair Care Entering the Nanotechnology Age

Yunhai Bio’s first consumer-grade product based on Tetrahedr...

Learn More

Yunhai Biotech has been selected for the first batch of "Top Solver" projects at the National Precision Medicine Industry Innovation Center

On November 28, 2024, the Precision Medicine Industry Innova...

Learn More

Professor Yunfeng Lin of Yunhai Bio Invited to Attend the "Sci-Tech Tianfu · Intelligence Converges in Chengdu" Technology Achievements Docking Event

On November 18, 2024, the "Sci-Tech Tianfu – Intelligence Co...

Learn More

Tetrahedral Framework Nucleic Acid Blue Book Event Successfully Held

On November 8, 2024, Tetrahedral Framework Nucleic Acid Blue...

Learn More

tFNA + miRNA: A Breakthrough in Ophthalmic Treatment

In 2024, the Nobel Prize in Physiology or Medicine was award...

Learn More

AI-Assisted Nucleic Acid Drug Development

In a remarkable coincidence, the 2024 Nobel Prize in Physics...

Learn More